Malaria,Falciparum
87
3
9
53
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
17 trials with published results (20%)
Research Maturity
53 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.7%
5 terminated out of 87 trials
91.4%
+4.8% vs benchmark
23%
20 trials in Phase 3/4
32%
17 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 53 completed trials
Clinical Trials (87)
Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi
A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
Pharmacokinetics of Antimalarials in Breastfeeding Ugandan Mother-infant Pairs
Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants
A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)
CHILD (Child Health and Infection With Low Density) Malaria
Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali
Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum
An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine
Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso
Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)
Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults
Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria
A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.
Safety and Efficacy of R0.6C Vaccine
A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults